Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Cytotherapy
|
May 24, 2016
Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells
David F Stroncek, Jiaqiang Ren, Daniel W Lee, et al.
Clinical Neurology and Neurosurgery
|
September 23, 2011
Muslin-induced intracranial vasculopathic stenosis: a report of two cases
Daniel W Lee, Mandy J Binning, Victoria K Shanmugam, et al.
Journal for Immunotherapy of Cancer
|
May 2, 2018
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan, Christopher Rota, Robbie Majzner, et al.
Journal of Translational Medicine
|
March 17, 2017
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
David F Stroncek, Daniel W Lee, Jiaqiang Ren, et al.
Transfusion
|
February 26, 2017
Autologous lymphapheresis for the production of chimeric antigen receptor T cells
Elizabeth S Allen, David F Stroncek, Jiaqiang Ren, et al.
Molecular Cancer Therapeutics
|
March 7, 2026
αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative Breast Cancer
Dustin A Cobb, Philip Mollica, Lixia Liu, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2020
Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies
Haneen Shalabi, Vandana Sachdev, Amita Kulshreshtha, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy
Haneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Research Square
|
November 21, 2023
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Blood Advances
|
July 24, 2023
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials
Sara K Silbert, Sanna Madan, Elizabeth M Holland, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Cytotherapy
|
May 24, 2016
Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells
David F Stroncek, Jiaqiang Ren, Daniel W Lee, et al.
Clinical Neurology and Neurosurgery
|
September 23, 2011
Muslin-induced intracranial vasculopathic stenosis: a report of two cases
Daniel W Lee, Mandy J Binning, Victoria K Shanmugam, et al.
Journal for Immunotherapy of Cancer
|
May 2, 2018
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan, Christopher Rota, Robbie Majzner, et al.
Journal of Translational Medicine
|
March 17, 2017
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
David F Stroncek, Daniel W Lee, Jiaqiang Ren, et al.
Transfusion
|
February 26, 2017
Autologous lymphapheresis for the production of chimeric antigen receptor T cells
Elizabeth S Allen, David F Stroncek, Jiaqiang Ren, et al.
Molecular Cancer Therapeutics
|
March 7, 2026
αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative Breast Cancer
Dustin A Cobb, Philip Mollica, Lixia Liu, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2020
Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies
Haneen Shalabi, Vandana Sachdev, Amita Kulshreshtha, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy
Haneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Research Square
|
November 21, 2023
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
Maxim Yankelevich, Archana Thakur, Shakeel Modak, et al.
Blood Advances
|
July 24, 2023
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials
Sara K Silbert, Sanna Madan, Elizabeth M Holland, et al.
Page
of 6